Merck, 1613429-1G, Sodium acetate trihydrate

General description
Peptide family: Teriparatide and Cosyntropin
This compound functions as a buffering agent in several biochemical applications and is part of the group of excipients and stabilizers used in peptide formulations.
The USP biologics peptides category encompasses a diverse range of therapeutic peptides that are essential in managing various medical conditions. These peptides, typically consisting of amino acid sequences of 40 residues or less, are critical for the development of high-quality medicines. The USP provides comprehensive standards, reference materials, and analytical procedures to ensure the identity, quality, purity, and consistency of peptide therapeutics throughout their lifecycle.
The United States Pharmacopeia (USP) provides quality standards for biologics to ensure their safety, efficacy, and quality throughout the manufacturing process. These standards assist manufacturers in adhering to regulatory requirements and help safeguard public health by reducing risks associated with biologics.

Application
Sodium acetate trihydrate USP reference standard, suitable for use in specified USP compendial tests and assays.

Also used to prepare standard solutions during the determination of the amount of acetic acid in peptides as described in United States Pharmacopeia (USP) general chapter
Analysis Note
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
Other Notes
Enzyme substrate for acetate kinase (EC 2.7.2.1)
Sales restrictions may apply.
This product is part of the USP Biologics program.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.